Background Image


June 14 - 15, 2016
Boston, Massachusetts

mHealth for Clinical Trials 2016

Article Image

Within the last year, the FDA has been actively encouraging the use of mHealth technology to enable faster, more cost effective trials that facilitate getting better drugs to patients, sooner. mHealth for Clinical Trials 2016 will address the technical, regulatory, and cultural barriers in the adoption of mobile and digital technology that can help transform the clinical trials process.

Georgia Mitsi, Apptomics founder and CEO, will discuss the importance of patient-centric design for engagement and adherence, as well as the importance of scientific validation for new mobile tools through a clinical trial process.

Article Image

The International Parkinson and Movement Disorder Society (MDS) is a professional society of clinicians, scientists, and other healthcare professionals interested in Parkinson’s disease, related neurodegenerative and neurodevelopmental disorders, hyperkinetic movement disorders, and abnormalities in muscle tone and motor control.

Apptomics Founder and CEO Georgia Mitsi will be sharing information on a first-of-its-kind digital study, one seeking to help generate data that could position qualified digital solutions as key components for Parkinson’s disease monitoring and management in both clinical trials and everyday care.